Journal of Thrombosis and Haemostasis, 1538-7933

Tidskrift

Fler filtreringsmöjligheter
  1. 40K glycoPEGylated, recombinant FVIIa: 3-month, double-blind, randomized trial of safety, pharmacokinetics, and preliminary efficacy in hemophilia patients with inhibitors.

    Rolf Ljung, Karim, F. A., Saxena, K., Suzuki, T., Arkhammar, P., Rosholm, A. & Giangrande, P., 2013, I : Journal of Thrombosis and Haemostasis. 11, 7, s. 1260-1268

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  2. Activated protein C resistance - in the absence of factor V Leiden - and pregnancy.

    Lindqvist, P. G., Svensson, P. & Björn Dahlbäck, 2006, I : Journal of Thrombosis and Haemostasis. 4, 2, s. 361-366

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. An evaluation of monitoring possibilities of argatroban using rotational thromboelastometry and aPTT

    Ulf Schött, Rundgren, M. & Engström, M., 2009, I : Journal of Thrombosis and Haemostasis. 7, s2, s. 871-872 PP-WE-721.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  4. Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding

    Ajzner, E., Balogh, I., Haramura, G., Boda, Z., Kalmar, K., Pfliegler, G., Björn Dahlbäck & Muszbek, L., 2003, I : Journal of Thrombosis and Haemostasis. 1, 5, s. 943-949

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. APC-PCI complex as new tool for the evaluation of anticoagulant response to endogenous thrombin formation and its sequel in fibrinolysis

    Kluft, C., Johan Stenflo, Meijer, P. & Burggraaf, J., 2010, I : Journal of Thrombosis and Haemostasis. 8, s. 58-58

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  6. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)

    Tosetto, A., Rodeghiero, F., Castaman, G., Goodeve, A., Federici, AB., Batlle, J., Meyer, D., Fressinaud, E., Mazurier, C., Goudemand, J., Eikenboom, J., Schneppenheim, R., Budde, U., Ingerslev, J., Vorlova, Z., Habart, D., Holmberg, L., Lethagen, S., Pasi, J., Hill, F. & 1 andraPeake, I., 2006, I : Journal of Thrombosis and Haemostasis. 4, 4, s. 766-773

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. A Randomized Clinical Trial of Prophylaxis in Children with Hemophilia A (the ESPRIT Study).

    Gringeri, A., Björn Lundin, Mackensen, S. V., Mantovani, L. & Mannucci, P. M., 2011, I : Journal of Thrombosis and Haemostasis. 9, s. 700-710

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Are randomized clinical trials the only truth? Not always

    Aledort, L., Rolf Ljung & Blanchette, V., 2006, I : Journal of Thrombosis and Haemostasis. 4, 3, s. 503-504

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  9. Autologous plasma for the study of anaphylatoxinkinetics in man

    Ulf Schött & Norda, R., 2009, I : Journal of Thrombosis and Haemostasis. 7, s2, PP-MO-672.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  10. Bedside point of care coagulation testing forindividualized antivitamin K reversal in emergencysurgery

    Ulf Schött, Winstedt, D. & Anveden, P., 2009, I : Journal of Thrombosis and Haemostasis. 7, s2, s. 1167 1 s., PP-TH-695.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  11. Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B

    Seron, V. M., Marx, P. F., Marquart, J. A., Heiko Herwald, de Groot, P. G. & Meijers, J. C. M., 2010, I : Journal of Thrombosis and Haemostasis. 8, s. 20-21

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  12. Bio-distribution of pharmacologically administered recombinant factor VIIa (rFVIIa)

    Gopalakrishnan, R., Hedner, U., Ghosh, S., Nayak, R. C., Allen, T. C., Pendurthi, U. R. & Rao, L. V. M., 2010, I : Journal of Thrombosis and Haemostasis. 8, 2, s. 301-310

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

    Collins, P. W., Blanchette, V. S., Fischer, K., Bjorkman, S., Oh, M., Fritsch, S., Schroth, P., Spotts, G., Jan Astermark & Ewenstein, B., 2009, I : Journal of Thrombosis and Haemostasis. 7, 3, s. 413-420

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. Can proteins induced by vitamin K absence - PIVKA-II - detect subclinical vitamin k deficit in major surgery?

    Ulf Schött, Anveden, P., Strandberg, K., Flisberg, P., Engström, M. & Hillarp, A., 2009, I : Journal of Thrombosis and Haemostasis. 7, s2, s. 404 PP-MO-258.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  15. Comparison of two different heparin doses inperipheral vascular surgery

    Ulf Schött & DAG WINSTEDT, 2009, I : Journal of Thrombosis and Haemostasis. 7, s2, PP-TH-359.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  16. Comparison of two infusionrates of antithrombinconcentrate in cardiopulmonary bypass surgery

    Ulf Schött, Carlsson, T. & Lund, P., 2009, I : Journal of Thrombosis and Haemostasis. 7, s2, s. 1075 1 s., PP-TH-428.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  17. Co-segregation of the PROS1 locus and protein S deficiency in families having no detectable mutations in PROS1.

    Lanke, E., Johansson, A., Andreas Hillarp, Lethagen, S., Bengt Zöller, Björn Dahlbäck & Halldén, C., 2004, I : Journal of Thrombosis and Haemostasis. 2, 11, s. 1918-1923

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Definitions in hemophilia: communication from the SSC of the ISTH

    Blanchette, V. S., Key, N. S., Rolf Ljung, Manco-Johnson, M. J., Van Den Berg, H. M. & Srivastava, A., 2014, I : Journal of Thrombosis and Haemostasis. 12, 11, s. 1935-1939

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Demographic and clinical data in acquired hemophilia a: results from the european acquired haemophilia (each2) registry.

    Knoebl, P., Paese, M., Baudo, F., Collins, P., Huth-Kühne, A., Nemes, L., Pellegrini, F., Lilian Tengborn & Lévesque, H., 2012, I : Journal of Thrombosis and Haemostasis. 10, 4, s. 622-631

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Desmopressin (DDAVP) and factor VIII

    Lars Holmberg, 2003, I : Journal of Thrombosis and Haemostasis. 1, 9, s. 2046-2047

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  21. Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)

    Budde, U., Schneppenheim, R., Eikenboom, J., Goodeve, A., Will, K., Drewke, E., Castaman, G., Rodeghiero, F., Federici, A. B., Batlle, J., Perez, A., Meyer, D., Mazurier, C., Goudemand, J., Ingerslev, J., Habart, D., Vorlova, Z., Holmberg, L., Lethagen, S., Pasi, J. & 2 andraHill, F. & Peake, I., 2008, I : Journal of Thrombosis and Haemostasis. 6, 5, s. 762-771

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Does an active sun exposure habit lower the risk of venous thrombotic events? A D-lightful hypothesis

    Lindqvist, P. G., Epstein, E. & Håkan Olsson, 2009, I : Journal of Thrombosis and Haemostasis. 7, 4, s. 605-610

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. Effect of late prophylaxis in hemophilia on joint status: A randomized trial

    Manco-Johnson, M. J., B. Lundin, Funk, S., Peterfy, C., Raunig, D., Werk, M., Kempton, C. L., Reding, M. T., Goranov, S., Gercheva, L., Rusen, L., Uscatescu, M. V., Pierdominici, M., Engelen, S., Pocoski, J., Walker, D. & Hong, W., 2017 nov, I : Journal of Thrombosis and Haemostasis. 15, 11, s. 2115-2124

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Effects of recombinant human prothrombin on thrombin generation in plasma from patients with haemophilia A and B.

    Hansson, K. M., Gustafsson, D., Skärby, T., Frison, L. & Erik Berntorp, 2015, I : Journal of Thrombosis and Haemostasis. 13, 7, s. 1293-1300

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-Xa assays.

    Andreas Hillarp, Gustafsson, K. M., Faxälv, L., Strandberg, K., Baghaei, F., Fagerberg Blixter, I., Berndtsson, M. & Lindahl, T. L., 2014, I : Journal of Thrombosis and Haemostasis. 12, 9, s. 1545-1553

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays.

    Andreas Hillarp, Baghaei, F., Blixter, I. F., Gustafsson, K. M., Stigendal, L., Sten-Linder, M., Strandberg, K. & Lindahl, T. L., 2011, I : Journal of Thrombosis and Haemostasis. 9, s. 133-139

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Elevated risk of venous but not arterial thrombosis in Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma

    Hultcrantz, M., Pfeiffer, R. M., Bjorkholm, M., Goldin, L. R., Ingemar Turesson, Schulman, S., Landgren, O. & Kristinsson, S. Y., 2014, I : Journal of Thrombosis and Haemostasis. 12, 11, s. 1816-1821

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIa.

    Clark, C. A., Vatsyayan, R., Hedner, U., Esmon, C. T., Pendurthi, U. R. & Rao, L. V. M., 2012, I : Journal of Thrombosis and Haemostasis. 10, 11, s. 2383-2391

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. Etonogestrel implant use is not related to hypercoagulable changes in anticoagulant system.

    Lindqvist, P. G., Rosing, J., Malmquist, A. & Andreas Hillarp, 2003, I : Journal of Thrombosis and Haemostasis. 1, 3, s. 601-602

    Forskningsoutput: TidskriftsbidragLetter

  30. Exposure to factor VIII and prediction of inhibitor development: exposure days vs. danger days, or both?

    Hermans, C., Jan Astermark & De Moerloos, P., 2012, I : Journal of Thrombosis and Haemostasis. 10, 10, s. 2194-2196

    Forskningsoutput: TidskriftsbidragLetter

  31. Factor H binds to washed human platelets.

    Vaziri-Sani, F., Hellwage, J., Zipfel, P. F., Sjöholm, A., Iancu, R. & Diana Karpman, 2005, I : Journal of Thrombosis and Haemostasis. 3, 1, s. 154-162

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Familial thrombophilia and lifetime risk of venous thrombosis

    Vossen, CY., Conard, J., Fontcuberta, J., Makris, M., Van Der Meer, FJM., Pabinger, I., Palareti, G., Preston, FE., Scharrer, I., Souto, JC., Peter Svensson, Walker, ID. & Rosendaal, FR., 2004, I : Journal of Thrombosis and Haemostasis. 2, 9, s. 1526-1532

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. Family history of venous thromboembolism is associated with increased risk for thrombosis in multiple myeloma: a population-based study.

    Kristinsson, S. Y., Goldin, L., Ingemar Turesson, Hultcrantz, M., Björkholm, M. & Landgren, O., 2012, I : Journal of Thrombosis and Haemostasis. 10, 5, s. 962-964

    Forskningsoutput: TidskriftsbidragLetter

  34. Family secrets to be disclosed.

    Lindqvist, P. G. & Joyce Carlson, 2006, I : Journal of Thrombosis and Haemostasis. 4, 10, s. 2180-2181

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  35. Fresh frozen plasma reduces thrombin formation in newborn infants

    Hyytiainen, S., Syrjala, M., Vineta Fellman, Heikinheimo, M. & Petaja, J., 2003, I : Journal of Thrombosis and Haemostasis. 1, 6, s. 1189-1194

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. From gamma-carboxy-glutamate to protein C.

    Johan Stenflo, 2006, I : Journal of Thrombosis and Haemostasis. 4, 12, s. 2521-2526

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. Functional analysis of the EGF-like domain mutations Pro55Ser and Pro55Leu, which cause mild hemophilia B.

    Knobe, K., Kristina Persson, Sjörin, E., Villoutreix, B. O., Johan Stenflo & Rolf Ljung, 2003, I : Journal of Thrombosis and Haemostasis. 1, 4, s. 782-790

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. Gas6 is complexed to soluble tyrosine kinase receptor Axl in human blood.

    Carl Ekman, Stenhoff, J. & Björn Dahlbäck, 2010, I : Journal of Thrombosis and Haemostasis. 8, 4, s. 838-844

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. Genetic analysis of 31 Swedish type 1 von Willebrand disease families reveals incomplete linkage to the von Willebrand factor gene and a high frequency of a certain disease haplotype.

    Lanke, E., Johansson, A., Halldén, C. & Lethagen, S., 2005, I : Journal of Thrombosis and Haemostasis. 3, 12, s. 2656-2663

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. Genome-wide analysis of genetic determinants of circulating factor VII-activating protease (FSAP) activity

    Olsson, M., Stanne, T. M., Pedersen, A., Lorentzen, E., Kara, E., Martinez-Palacian, A., Rønnow Sand, N. P., Jacobsen, A. F., Sandset, P. M., Sidelmann, J. J., G. Engström, O. Melander, Kanse, S. M. & Jern, C., 2018, I : Journal of Thrombosis and Haemostasis. 16, 10, s. 2024-2034

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination - a rebuttal

    Egberg, N., Fagerberg, I., Andreas Hillarp, Lindahl, TL. & Stigendal, L., 2005, I : Journal of Thrombosis and Haemostasis. 3, 10, s. 2370-2371

    Forskningsoutput: TidskriftsbidragLetter

  42. Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study

    Castaman, G., Rodeghiero, F., Tosetto, A., Cappelletti, A., Baudo, F., Eikenboom, J. C. J., Federici, A. B., Lethagen, S., Linari, S., Lusher, J., Nishino, M., Petrini, P., Srivastava, A. & Ungerstedt, J. S., 2006, I : Journal of Thrombosis and Haemostasis. 4, 10, s. 2164-2169

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. Hereditary thrombophilia and fetal loss: a prospective follow-up study

    Vossen, CY., Preston, FE., Conard, J., Fontcuberta, J., Makris, M., Van Der Meer, FJM., Pabinger, I., Palareti, G., Scharrer, I., Souto, JC., Peter Svensson, Walker, ID. & Rosendaal, FR., 2004, I : Journal of Thrombosis and Haemostasis. 2, 4, s. 592-596

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  44. Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)

    Tosetto, A., Rodeghiero, F., Castaman, G., Bernardi, M., Bertoncello, K., Goodeve, A., Federici, A. B., Batlle, J., Meyer, D., Mazurier, C., Goudemand, J., Eikenboom, J., Schneppenheim, R., Budde, U., Ingerslev, J., Vorlova, Z., Habart, D., Holmberg, L., Lethagen, S., Pasi, J. & 2 andraHill, F. & Peake, I., 2007, I : Journal of Thrombosis and Haemostasis. 5, 4, s. 715-721

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  45. Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A

    Pavlova, A., Delev, D., Lacroix-Desmazes, S., Schwaab, R., Mende, M., Fimmers, R., Jan Astermark & Oldenburg, J., 2009, I : Journal of Thrombosis and Haemostasis. 7, 12, s. 2006-2015

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay using a novel automated assay protocol.

    Andreas Hillarp, Stadler, M., Haderer, C., Weinberger, J., Kessler, C. M. & Römisch, J., 2010, I : Journal of Thrombosis and Haemostasis. 8, s. 2216-2223

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  47. Incidence and risk of venous thromboembolism in patients with verified arterial thrombosis: a population study based on 23 796 consecutive autopsies

    Eliasson, A., Bergqvist, D., Bjorck, M., Stefan Acosta, Sternby, N. & Ogren, M., 2006, I : Journal of Thrombosis and Haemostasis. 4, 9, s. 1897-1902

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  48. Induction of Auto-Antibodies Against β(2) -Glycoprotein I in Mice by Protein H of Streptococcus Pyogenes.

    van Os, G. M. A., Meijers, J. C. M., Ağar, C., Valls Serón, M., Marquart, J. A., Per Åkesson, Urbanus, R. T., Derksen, R. H. W. M., Heiko Herwald, Mörgelin, M. & de Groot, P. G., 2011, I : Journal of Thrombosis and Haemostasis. 9, 12, s. 2447-2456

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  49. Influence of endothelial cell protein C receptor on plasma clearance of factor VIIa.

    Gopalakrishnan, R., Pendurthi, U. R., Hedner, U., Agersø, H., Esmon, C. T. & Rao, L. V. M., 2012, I : Journal of Thrombosis and Haemostasis. 10, 5, s. 971-973

    Forskningsoutput: TidskriftsbidragLetter

  50. Influence of endotoxin challenge on protein S and C4b-binding protein in healthy subjects

    Krabbe, KS., Bruunsgaard, H., Andreas Hillarp & Thorsen, S., 2006, I : Journal of Thrombosis and Haemostasis. 4, 3, s. 692-694

    Forskningsoutput: TidskriftsbidragLetter

  51. Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients: Results of the INSIGHT case-control study

    van Velzen, A. S., Eckhardt, C. L., Peters, M., Leebeek, F. W. G., Escuriola-Ettingshausen, C., Hermans, C., Keenan, R. D., J. Astermark, Male, C., Peerlinck, K., le Cessie, S., Van der Bom, J. G. & Fijnvandraat, K., 2017 jul 3, I : Journal of Thrombosis and Haemostasis. 15, 7, s. 1422-1429

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  52. Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD

    Eikenboom, J., Van Marion, V., Putter, H., Goodeve, A., Rodeghiero, F., Castaman, G., Federici, AB., Batlle, J., Meyer, D., Mazurier, C., Goudemand, J., Schneppenheim, R., Budde, U., Ingerslev, J., Vorlova, Z., Habart, D., Holmberg, L., Lethagen, S., Pasi, J., Hill, F. & 1 andraPeake, I., 2006, I : Journal of Thrombosis and Haemostasis. 4, 4, s. 774-782

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  53. Low molecular weight heparin for repeated pregnancy loss: is it based on solid evidence?

    Lindqvist, P. G. & Juan Merlo, 2005, I : Journal of Thrombosis and Haemostasis. 3, 2, s. 221-223

    Forskningsoutput: TidskriftsbidragLetter

  54. Measuring factor IX activity of nonacog beta pegol with commercially available one-stage clotting and chromogenic assay kits: A two-center study

    Bowyer, A. E., A. Hillarp, Ezban, M., Persson, P. & Kitchen, S., 2016, I : Journal of Thrombosis and Haemostasis. 14, 7, s. 1428-1435

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  55. Molecular recognition in the protein C anticoagulant pathway.

    Björn Dahlbäck & Villoutreix, B. O., 2003, I : Journal of Thrombosis and Haemostasis. 1, 7, s. 1525-1534

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  56. Monitoring the bioavailability of FEIBA with a thrombin generation assay

    Varadi, K., Negrier, C., Erik Berntorp, Jan Astermark, Bordet, JC., Morfini, M., Linari, S., Schwarz, HP. & Turecek, PL., 2003, I : Journal of Thrombosis and Haemostasis. 1, 11, s. 2374-2380

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  57. Mortality and Inherited Thrombophilia: results from the European Prospective Cohort on Thrombophilia (EPCOT).

    Pabinger, I., Vossen, C. Y., Lang, J., Conard, J., García-Dabrio, M. C., Miesbach, W., Legnani, C., Peter Svensson, Kaider, A. & Rosendaal, F. R., 2012, I : Journal of Thrombosis and Haemostasis. 10, 2, s. 217-222

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  58. New functional test for the TFPIα cofactor activity of Protein S working in synergy with FV-Short

    Björn Dahlbäck, Guo, L. J., Bengt Zöller & Tran, S., 2019, I : Journal of Thrombosis and Haemostasis. 17, 4, s. 585-595

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  59. Novel APC-cleavage sites in FVa providing insights into mechanisms of action of APC and its cofactor protein S.

    Tran, S. & Björn Dahlbäck, 2010, I : Journal of Thrombosis and Haemostasis. 8, 1, s. 129-136 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  60. Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S

    B. Dahlbäck, 2017 jul 1, I : Journal of Thrombosis and Haemostasis. 15, 7, s. 1241-1250 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  61. Origin of Swedish hemophilia A mutations

    Halldén, C., Nilsson, D., Torbjörn Säll, Lind-Hallden, C., Liden, A. C. & Rolf Ljung, 2012, I : Journal of Thrombosis and Haemostasis. 10, 12, s. 2503-2511

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  62. Origin of Swedish hemophilia B mutations

    Hallden, C., Annika Mårtensson, Nilsson, D., Torbjörn Säll, Lind-Hallden, C., Liden, A. C. & Rolf Ljung, 2013, I : Journal of Thrombosis and Haemostasis. 11, 11, s. 2001-2008

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  63. Pharmacokinetic studies on Wilfactin((R)), a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods

    Goudemand, J., Scharrer, I., Erik Berntorp, Lee, CA., Borel-Derlon, A., Stieltjes, N., Caron, C., Scherrmann, JM., Bridey, F., Tellier, Z., Federici, AB. & Mannucci, PM., 2005, I : Journal of Thrombosis and Haemostasis. 3, 10, s. 2219-2227

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  64. Platelet shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal sepsis.

    Milladur Rahman, Zhang, S., Chew, M., Ingvar Syk, Bengt Jeppsson & Henrik Thorlacius, 2013, I : Journal of Thrombosis and Haemostasis. 11, 7, s. 1385-1398

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  65. Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A

    Jan Astermark, Wang, X., Oldenburg, J., Erik Berntorp & Lefvert, A. -K., 2007, I : Journal of Thrombosis and Haemostasis. 5, 2, s. 263-265

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  66. Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9-GP), a glycoPEGylated recombinant factor IX.

    Collins, P. W., Møss, J., Knobe, K., Groth, A., Colberg, T. & Watson, E., 2012, I : Journal of Thrombosis and Haemostasis. 10, 11, s. 2305-2312

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  67. Population Pharmacokinetics of Plasma-Derived Factor IX: Procedures for Dose Individualization.

    Brekkan, A., Erik Berntorp, Jensen, K., Nielsen, E. I. & Jönsson, S., 2016, I : Journal of Thrombosis and Haemostasis. 14, 4, s. 724-732

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  68. Post-translational modifications in proteins involved in blood coagulation.

    Hansson, K. M. & Johan Stenflo, 2005, I : Journal of Thrombosis and Haemostasis. 3, 12, s. 2633-2648

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  69. Potential role of rFVIIa in prophylaxis in severe haemophilia patients with inhibitors.

    Hedner, U., 2006, I : Journal of Thrombosis and Haemostasis. 4, Aug 14, s. 2498-2500

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  70. Prophylaxis Escalation in Severe von Willebrand Disease: A Prospective Study from the von Willebrand Disease Prophylaxis Network.

    Abshire, T., Cox-Gill, J., Kempton, C. L., Leebeek, F. W. G., Carcao, M., Kouides, P., Donfield, S. & Erik Berntorp, 2015, I : Journal of Thrombosis and Haemostasis. 13, 9, s. 1585-1589

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  71. Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia - a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study.

    Tuckuviene, R., Ranta, S., Albertsen, B. K., Andersson, N. G., Bendtsen, M. D., Frisk, T., Gunnes, M. W., Helgestad, J., Heyman, M. M., Jonsson, O. G., Mäkipernaa, A., Pruunsild, K., Ulf Tedgård, Trakymiene, S. S. & Ruud, E., 2016, I : Journal of Thrombosis and Haemostasis. 14, 3, s. 485-494

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  72. Prothrombin complex concentrate and effects on thecone and plate analyser

    Ulf Schött, Jirgård, L., Strandberg, K. & Hillarp, A., 2009, I : Journal of Thrombosis and Haemostasis. 7, s2, s. 885 1 s., PP-WE-758.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  73. Quantification of ADP and ATP receptor expression in human platelets.

    Wang, L., Ostberg, O., Anna-Karin Wihlborg, Brogren, H., Jern, S. & David Erlinge, 2003, I : Journal of Thrombosis and Haemostasis. 1, 2, s. 330-336

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  74. Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats

    Lauritzen, B., Hedner, U., Johansen, P. B., Tranholm, M. & Ezban, M., 2008, I : Journal of Thrombosis and Haemostasis. 6, 5, s. 804-811

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  75. Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following IV administration in haemophilia patients.

    Agersø, H., Brophy, D. F., Pelzer, H., Martin, E. J., Carr, M., Hedner, U. & Ezban, M., 2011, I : Journal of Thrombosis and Haemostasis. 9, 2, s. 333-338

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  76. rFVIIa transported from the blood stream into tissues is functionally active

    Gopalakrishnan, R., Hedner, U., Clark, C., Pendurthi, U. R. & Rao, L. V. M., 2010, I : Journal of Thrombosis and Haemostasis. 8, 10, s. 2318-2321

    Forskningsoutput: TidskriftsbidragLetter

  77. Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)

    Vossen, CY., Conard, J., Fontcuberta, J., Makris, M., Van der Meer, FJM., Pabinger, I., Palareti, G., Preston, FE., Scharrer, I., Souto, JC., Peter Svensson, Walker, ID. & Rosendaal, FR., 2005, I : Journal of Thrombosis and Haemostasis. 3, 3, s. 459-464

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  78. Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa).

    Tiede, A., Friedrich, U., Stenmo, C., Allen, G., Giangrande, P., Goudemand, J., Hay, C., Holmström, E. M., Klamroth, R., Lethagen, S., McKenzie, S., Miesbach, W., Negrier, C., Yuste, V. J. & Erik Berntorp, 2011, I : Journal of Thrombosis and Haemostasis. 9, s. 1191-1199

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  79. Soluble thrombomodulin activity and soluble thrombomodulin antigen in plasma.

    Öhlin, A-K., Larsson, K. & Hansson, M., 2005, I : Journal of Thrombosis and Haemostasis. 3, 5, s. 976-982

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  80. Succinate independently stimulates full platelet activation via cAMP and PI3β kinase signaling.

    Högberg, C., Olof Gidlöf, Tan, C., Svensson, S., Öhman, J., David Erlinge & Björn Olde, 2011, I : Journal of Thrombosis and Haemostasis. 9, 2, s. 361-372

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  81. Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice

    Annika Jögi, Pass, J., Hoyer-Hansen, G., Lund, L. R., Nielsen, B. S., Dano, K. & Romer, J., 2007, I : Journal of Thrombosis and Haemostasis. 5, 9, s. 1936-1944

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  82. The activation peptide of thrombin-activatable fibrinolysis inhibitor: a role in activity and stability of the enzyme?

    Marx, P. F., Plug, T., Havik, S. R., Mörgelin, M. & Meijers, J. C. M., 2009, I : Journal of Thrombosis and Haemostasis. 7, 3, s. 445-452

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  83. The cleaved and latent forms of antithrombin are normal constituents of blood plasma: a quantitative method to measure cleaved antithrombin.

    Kjellberg, M., Ikonomou, T. & Johan Stenflo, 2006, I : Journal of Thrombosis and Haemostasis. 4, 1, s. 168-176

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  84. The discovery of activated protein C resistance.

    Björn Dahlbäck, 2003, I : Journal of Thrombosis and Haemostasis. 1, 1, s. 3-9

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  85. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study

    Rodeghiero, F., Castaman, G., Tosetto, A., Batlle, J., Baudo, F., Cappelletti, A., Casana, P., De Bosch, N., Eikenboom, JCJ., Federici, AB., Lethagen, S., Linari, S. & Srivastava, A., 2005, I : Journal of Thrombosis and Haemostasis. 3, 12, s. 2619-2626

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  86. The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A

    Eckhardt, C. L., Jan Astermark, Nagelkerke, S. Q., Geissler, J., Tanck, M. W. T., Peters, M., Fijnvandraat, K. & Kuijpers, T. W., 2014, I : Journal of Thrombosis and Haemostasis. 12, 8, s. 1294-1301

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  87. The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation.

    Kozarcanin, H., Lood, C., Munthe-Fog, L., Sandholm, K., Hamad, O. A., Anders Bengtsson, Skjoedt, M-O., Huber-Lang, M., Garred, P., Ekdahl, K. N. & Nilsson, B., 2016, I : Journal of Thrombosis and Haemostasis. 14, 3, s. 531-545

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 Nästa